Janet S. Wright

2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery

Alice K. Jacobs, MD, FACC, FAHA, Chair Jeffrey L. Anderson, MD, FACC, FAHA, Chair-Elect Nancy Albert, PhD, CCNS, CCRN, FAHA Mark A. Creager, MD, FACC, FAHA Steven M. Ettinger, MD, FACC Robert A. Guyton, MD, FACC Jonathan L. Halperin, MD, FACC, FAHA Judith S. Hochman, MD, FACC, FAHA

2011 ACCF/AHA guideline for coronary artery bypass graft surgery: Executive summary

2011;58;2584-2614; originally published online Nov 7, 2011; J. Am. Coll. Cardiol. Winniford Joseph F. Sabik, Ola Selnes, David M. Shahian, Jeffrey C. Trost, and Michael D. A. Lange, Martin J. London, Michael J. Mack, Manesh R. Patel, John D. Puskas, Adolph M. Hutter, Jr, Michael E. Jessen, Ellen C. Keeley, Stephen J. Lahey, Richard Bridges, John G. Byrne, Joaquin E. Cigarroa, Verdi J. DiSesa, Loren F. Hiratzka, L. David Hillis, Peter K. Smith, Jeffrey L. Anderson, John A. Bittl, Charles R. Surgeons Surgery, Society of Cardiovascular Anesthesiologists, and Society of Thoracic Developed in Collaboration With the American Association for Thoracic Foundation/American Heart Association Task Force on Practice Guidelines Executive Summary: A Report of the American College of Cardiology 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: This information is current as of January 22, 2012 http://content.onlinejacc.org/cgi/content/full/58/24/2584 located on the World Wide Web at: The online version of this article, along with updated information and services, is

ACCF 2008 health policy statement on principles for public reporting of physician performance data: A Report of the American College of Cardiology Foundation Writing Committee to develop principles for public reporting of physician performance data.

Janet S. Wright, MD, FACC, Chair Kathleen Blake, MD, FACC Robert O. Bonow, MD, FACC Ralph G. Brindis, MD, FACC John E. Brush, Jr, MD, FACC Joseph G. Cacchione, MD, FACC Gregory J. Dehmer, MD, FACC Joseph P. Drozda, Jr, MD, FACC Kim A. Eagle, MD, FACC James W. Fasules, MD, FACC Kathleen B

Estimating Longitudinal Risks and Benefits From Cardiovascular Preventive Therapies Among Medicare Patients: The Million Hearts Longitudinal ASCVD Risk Assessment Tool: A Special Report From the American Heart Association and American College of Cardiology

The Million Hearts Initiative has a goal of preventing 1 million heart attacks and strokes—the leading causes of mortality—through several public health and healthcare strategies by 2017. The American Heart Association and American College of Cardiology support the program. The Cardiovascular Risk Reduction Model was developed by Million Hearts and the Center for Medicare & Medicaid Services as a strategy to assess a value-based payment approach toward reduction in 10-year predicted risk of atherosclerotic cardiovascular disease (ASCVD) by implementing cardiovascular preventive strategies to manage the “ABCS” (aspirin therapy in appropriate patients, blood pressure control, cholesterol management, and smoking cessation). The purpose of this special report is to describe the development and intended use of the Million Hearts Longitudinal ASCVD Risk Assessment Tool. The Million Hearts Tool reinforces and builds on the “2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk” by allowing clinicians to estimate baseline and updated 10-year ASCVD risk estimates for primary prevention patients adhering to the appropriate ABCS over time, alone or in combination. The tool provides updated risk estimates based on evidence from high-quality systematic reviews and meta-analyses of the ABCS therapies. This novel approach to personalized estimation of benefits from risk-reducing therapies in primary prevention may help target therapies to those in whom they will provide the greatest benefit, and serves as the basis for a Center for Medicare & Medicaid Services program designed to evaluate the Million Hearts Cardiovascular Risk Reduction Model.

ACC 2009 Advocacy Position Statement: Principles for Comparative Effectiveness Research

Vincent J. Bufalino, MD, FACC, Co-Chair Fred M. Krainin, MD, FACC, Co-Chair James C. Blankenship, MD, FACC Kenneth Brin, MD, PHD, FACC Paul N. Casale, MD, FACC Jerry D. Kennett, MD, FACC Joseph V. Messer, MD, MACC Frank Mikkell, JR, MD, FACC George P. Rodgers, MD, FACC Jane E. Schauer, MD

Is Rapid Health Improvement Possible

Five years ago, the Centers for Disease Control and Prevention, the Centers for Medicare & Medicaid Services, and partners launched a public–private initiative to prevent 1 million heart attacks and strokes by 2017.1 Although final results will not be known for several years, data suggest that the initiative made substantial progress and will achieve about half of its goal. Policies, partnerships, and programs prevented cardiovascular events and yielded important lessons. This article outlines the actions taken, progress made, and implications for health improvement in the United States. Cardiovascular disease (CVD) remains our leading cause of death, killing 800 000 Americans and costing

Characteristics of Health Care Practices and Systems That Excel in Hypertension Control

316 billion annually.2 CVD event and mortality rates have declined since the 1960s, but this decline decelerated around 2011.3 The Million Hearts initiative began in 2012 and faced the challenge of overcoming this trend. The purpose of the initiative was to scale effective interventions in order to prevent CVD events to resume and accelerate the decline.1 Communitywide goals were to reduce tobacco use and sodium intake and to eliminate artificial trans fat consumption. Clinical priorities were to improve management of the ABCS: aspirin use, blood pressure control, cholesterol management, and smoking cessation. More than 120 partners, including federal, state, local, and private sector organizations, are working to achieve targets. Through the first 2 years of the initiative, ≈115 000 events …

America's Health Insurance Plans

Approximately 1 in 3 US adults has hypertension, but only half have their blood pressure controlled. We identified characteristics of health care practices and systems (hereinafter practices) effective in achieving control rates at or above 70% by using data collected via applications submitted from April through June 2017 for consideration in the Million Hearts Hypertension Control Challenge. We included 96 practices serving 635,000 patients with hypertension across 34 US states in the analysis. Mean hypertension control rate was 77.1%; 27.1% of practices had a control rate of 80% or greater. Although many practices served large populations with multiple risk factors for uncontrolled hypertension, high control rates were achieved with implementation of evidenced-based strategies.